Artelo Biosciences- Warrants (18/06/2024) Operating Income

As of the most recent data (June 2026), ARTLW shows a operating income of $-11M. That compares with $-11M in the prior-year period — down 5.1% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, ARTLW's operating income is now $-11M (was $-11M) — a 5.1% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Artelo Biosciences- Warrants (18/06/2024) is outperforming or lagging.

Tracking ARTLW's operating income over time shows whether Artelo Biosciences- Warrants (18/06/2024) is scaling, shrinking, or reshaping that part of the business. The current reading is $-11M That compares with $-11M in the prior-year period — down 5.1% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this operating income page, Stockcircle has Artelo Biosciences- Warrants (18/06/2024)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect operating income (currently $-11M) with ownership activity and broader fundamentals.

Artelo Biosciences- Warrants (18/06/2024)'s operating income is $-11M; compare it with other Consumer Staples names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.